AMERICA'S MOST TRUSTED® HOMEBUILDER PARTNERS WITH LAS VEGAS STAPLE FREED'S BAKERY TO CREATE A DIY GINGERBREAD HOUSE KIT THAT GIVES BACK SCOTTSDALE, ARIZ. , NOV. 5, 2025 /PRNEWSWIRE/ -- AMERICA'S MOST TRUSTED® HOME BUILDER TAYLOR MORRISON (NYSE: TMHC) IS HELPING TO SAVE HOMEOWNERS FROM FORECLOSURE THIS HOLIDAY SEASON WITH THE CREATION OF THE BUILD JOY GINGERBREAD HOUSE KIT—A GIFT THAT GIVES BACK.
TMHC
• Nov. 5, 2025
TARGET'S THANKSGIVING MEAL FOR FOUR IS LESS THAN $5 PER PERSON, PLUS GOOD & GATHER TURKEY RETURNS AT 2024'S PRICE OF JUST 79 CENTS PER POUND ONLY AT TARGET, CONSUMERS CAN FIND THE JOY IN AFFORDABLY SHOPPING FOR A TASTY MEAL ALONGSIDE TRENDING TABLE DÉCOR AND MORE TO CREATE A MEMORABLE CELEBRATION RETAILER ADDS HARRY & DAVID, HEARTH & HAND WITH MAGNOLIA TABLE, JOHN DERIAN FOR TARGET, STONEWALL KITCHEN, SUGARFINA AND MORE TO ITS SHELVES JUST IN TIME FOR THE HOLIDAYS MINNEAPOLIS , NOV. 5, 2025 /PRNEWSWIRE/ -- TARGET CORPORATION (NYSE: TGT) TODAY ANNOUNCED IT'S MAKING THANKSGIVING TASTIER, MORE STYLISH AND MORE AFFORDABLE THAN EVER BEFORE. BACK BY POPULAR DEMAND, TARGET'S HOLIDAY MEAL FOR FOUR RETURNS AT ITS LOWEST PRICE EVER — UNDER $20,1 LESS THAN $5 PER PERSON.
TGT
• Nov. 5, 2025
LONDON--(BUSINESS WIRE)---- $LIVN #OSA--LIVANOVA PLC (NASDAQ: LIVN), A MARKET-LEADING MEDICAL TECHNOLOGY COMPANY, TODAY REPORTED RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025 AND RAISED FULL-YEAR 2025 GUIDANCE. FINANCIAL SUMMARY AND HIGHLIGHTS(1) THIRD-QUARTER REVENUE OF $357.8 MILLION INCREASED 12.5% ON A REPORTED BASIS, 11.0% ON A CONSTANT-CURRENCY BASIS, AND 12.5% ON AN ORGANIC BASIS AS COMPARED TO THE PRIOR-YEAR PERIOD THIRD-QUARTER U.S. GAAP DILUTED EARNINGS PER SHARE OF $0.49 AND ADJUSTED DILUT.
LIVN
• Nov. 5, 2025
LOUISVILLE, KY.--(BUSINESS WIRE)--HUMANA INC. (NYSE: HUM) TODAY REPORTED CONSOLIDATED PRETAX RESULTS AND DILUTED EARNINGS PER SHARE (EPS) FOR THE QUARTER ENDED SEPTEMBER 30, 2025 (3Q25) VERSUS THE QUARTER ENDED SEPTEMBER 30, 2024 (3Q24) AND FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2025 (YTD 2025) VERSUS THE NINE MONTHS ENDED SEPTEMBER 30, 2024 (YTD 2024) AS NOTED IN THE TABLES BELOW. CONSOLIDATED INCOME BEFORE INCOME TAXES AND EQUITY IN NET LOSSES (PRETAX RESULTS) IN MILLIONS 3Q25 (A) 3Q24 (A) Y.
HUM
• Nov. 5, 2025
DULUTH, GA.--(BUSINESS WIRE)--NATIONAL VISION HOLDINGS, INC. (NASDAQ: EYE) (“NATIONAL VISION,” “WE,” “OUR,” “US” OR THE “COMPANY”) TODAY REPORTED ITS FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 27, 2025. "OUR STRONG PERFORMANCE THIS QUARTER DEMONSTRATES THAT OUR TEAM'S FOCUSED EXECUTION ON OUR INITIATIVES IS DELIVERING RESULTS," SAID ALEX WILKES, NATIONAL VISION'S CEO. "OUR MERCHANDISE STRATEGY IS WORKING, OUR ASSOCIATES ARE EMBRACING NEW SELLING TECHNIQUES, AND OUR NEW AMERICA'S BE.
EYE
• Nov. 5, 2025
CHICAGO--(BUSINESS WIRE)--COMPANY TO ACTIVELY DEPLOY SHARE REPURCHASE AUTHORIZATION REFLECTING CONFIDENCE IN COMPANY'S FUNDAMENTAL STRENGTH.
ATGE
• Nov. 5, 2025
ST. LOUIS--(BUSINESS WIRE)-- #EARNINGS--BUNGE GLOBAL SA (NYSE: BG) TODAY REPORTED THIRD QUARTER 2025 RESULTS.
BG
• Nov. 5, 2025
CHICAGO--(BUSINESS WIRE)--PARK HYATT CHICAGO PRESENTS THE GLENLIVET 55 LEGACY EXPERIENCE, A SINGULAR OFFERING CENTERED ON THE GLENLIVET 55 YEAR OLD – EDITION NO. 1.
H
• Nov. 5, 2025
KINGSTON, JAMAICA--(BUSINESS WIRE)--EXCELERATE ENERGY, INC. (NYSE: EE) ("EXCELERATE"), IN PARTNERSHIP WITH FOOD FOR THE POOR JAMAICA, PROJECT C.U.R.E., WORLD CENTRAL KITCHEN, THE OFFICE OF DISASTER PREPAREDNESS AND EMERGENCY MANAGEMENT (ODPEM), AND THE MINISTRY OF HEALTH AND WELLNESS (MOHW), TODAY ANNOUNCED THAT IT HAS MOBILIZED OVER ONE MILLION USD IN CRITICAL AID AND RESOURCES TO SUPPORT RELIEF AND RECOVERY EFFORTS ACROSS JAMAICA FOLLOWING THE DEVASTATION CAUSED BY HURRICANE MELISSA. THIS COO.
EE
• Nov. 5, 2025
MELBOURNE, AUSTRALIA AND INDIANAPOLIS, NOV. 05, 2025 (GLOBE NEWSWIRE) -- TELIX PHARMACEUTICALS LIMITED (ASX: TLX, NASDAQ: TLX, “TELIX”) WILL PARTICIPATE IN THE UPCOMING UBS GLOBAL HEALTHCARE CONFERENCE IN PALM BEACH, FL (U.S.) AND IN THE JEFFERIES GLOBAL HEALTHCARE CONFERENCE IN LONDON (UK).
UBS
• Nov. 5, 2025
GOUVERNEUR, N.Y., NOV. 05, 2025 (GLOBE NEWSWIRE) -- TITAN MINING CORPORATION (TSX: TI, OTCQB: TIMCF(1)) (“TITAN” OR THE “COMPANY”), AN EXISTING ZINC CONCENTRATE PRODUCER IN UPSTATE NEW YORK AND AN EMERGING NATURAL FLAKE GRAPHITE PRODUCER, A KEY COMPONENT IN THE BROADER RARE EARTHS AND CRITICAL MINERALS ECOSYSTEM, TODAY ANNOUNCED STRONG FINANCIAL AND OPERATIONAL RESULTS FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2025.
TIMCF
• Nov. 5, 2025
DSAP IS A PREMALIGNANT, PROGRESSIVE DISEASE CHARACTERIZED BY NUMEROUS EXPANDING LESIONS WHICH SIGNIFICANTLY IMPACT QUALITY-OF-LIFE; NO FDA-APPROVED THERAPIES EXIST FOR THE ESTIMATED MORE THAN 50,000 DIAGNOSED U.S. PATIENTS
GENE
• Nov. 5, 2025
KEY POINTS IMMURON RECEIVES U.S. FOOD AND DRUG ADMINISTRATION (FDA) APPROVAL FOR IMM-529 INVESTIGATIONAL NEW DRUG (IND) APPLICATION AND CLINICAL STUDY MAY PROCEED FDA ASSIGNED AN IND NUMBER (032095) FOR THE IMM-529 APPLICATION IND 32095 IS IMMURON'S INVESTIGATIONAL NEW DRUG (IND) APPLICATION FOR CLINICAL DEVELOPMENT OF IMM-529 AS PRODUCT TO SPECIFICALLY PREVENT OR TREAT CLOSTRIDIOIDES DIFFICILE INFECTION (CDI) AND IS NOW ACTIVE MELBOURNE, AUSTRALIA, NOV. 05, 2025 (GLOBE NEWSWIRE) -- IMMURON LIMITED (ASX: IMC; NASDAQ: IMRN), IS PLEASED TO ANNOUNCE THAT THE UNITED STATES FOOD AND DRUG ADMINISTRATION (FDA) HAS APPROVED IMMURON'S INVESTIGATIONAL NEW DRUG APPLICATION FOR IMM-529 AND THE PHASE 2 CLINICAL TRIAL MAY PROCEED. THE COMPANY PLANS TO INITIATE A PHASE 2 CLINICAL TRIAL FOR IMM-529 IN INDIVIDUALS WITH CLOSTRIDIOIDES DIFFICILE INFECTION (CDI) DURING THE FIRST HALF OF 2026.
IMRN
• Nov. 5, 2025
DEEPHEALTH COMMERCIALIZES REMOTE-IMAGING OFFERING FEATURING TECHLIVE™ REMOTE SCANNING AND ALPHA RT'S MRI STAFFING SERVICES, TRAINING AND SAFETY SOFTWARE.
RDNT
• Nov. 5, 2025
MARKS ACLARION'S FIRST COMMERCIAL SALES HIRE WITH SEASONED HEALTHTECH LEADER AND PROVEN TRACK RECORD OF ADVANCING MUSCULOSKELETAL IMAGING AND SPINAL SURGERY EXPERIENCING STRONG COMMERCIAL TRACTION IN UK AS FIRST MARKET WORLDWIDE WITH PRIVATE INSURERS COVERING NOCISCAN NOCISCAN REIMBURSED BY THREE OF TOP FOUR PRIVATE INSURERS IN UK, GIVING ACCESS TO MORE THAN 5.2 MILLION COVERED LIVES BROOMFIELD, COLO., NOV. 05, 2025 (GLOBE NEWSWIRE) -- ACLARION, INC. (“ACLARION” OR THE “COMPANY”) (NASDAQ: ACON, ACONW), A HEALTHCARE TECHNOLOGY COMPANY THAT IS LEVERAGING BIOMARKERS AND PROPRIETARY AUGMENTED INTELLIGENCE (AI) ALGORITHMS TO HELP PHYSICIANS IDENTIFY THE LOCATION OF CHRONIC LOW BACK PAIN, ANNOUNCED THE APPOINTMENT OF DAN ISHERWOOD AS UK COMMERCIAL DIRECTOR.
ACON
• Nov. 5, 2025
HOUSTON, NOV. 05, 2025 (GLOBE NEWSWIRE) -- TARGA RESOURCES CORP. (NYSE: TRGP) (“TRGP,” THE “COMPANY” OR “TARGA”) TODAY REPORTED THIRD QUARTER 2025 RESULTS.
TRGP
• Nov. 5, 2025
HOUSTON, NOV. 05, 2025 (GLOBE NEWSWIRE) -- AMPLIFY ENERGY CORP. (NYSE: AMPY) (“AMPLIFY,” THE “COMPANY,” “US,” OR “OUR”) ANNOUNCED TODAY IT HAS ENTERED INTO A DEFINITIVE AGREEMENT TO SELL ALL OF ITS INTERESTS IN OKLAHOMA FOR A TOTAL CONTRACT PRICE OF $92.5 MILLION, SUBJECT TO CUSTOMARY POST-CLOSING ADJUSTMENTS (THE “OKLAHOMA TRANSACTION”). THE OKLAHOMA TRANSACTION IS EXPECTED TO CLOSE BY THE END OF THE FOURTH QUARTER OF 2025 AND WILL REPRESENT A COMPLETE EXIT FROM THE COMPANY'S INTERESTS IN OKLAHOMA.
AMPY
• Nov. 5, 2025
VANCOUVER, BRITISH COLUMBIA--(NEWSFILE CORP. - NOVEMBER 5, 2025) - UNIVERSAL DIGITAL INC. (CSE: LFG) (OTCQB: LFGMF) (FSE: 8R20) ("UNIVERSAL DIGITAL" OR THE "COMPANY") IS PLEASED TO ANNOUNCE IT HAS ENTERED INTO A STRATEGIC PARTNERSHIP WITH CRYPTO.COM ON SEPTEMBER 25, 2025, A TRUSTED GLOBAL CRYPTOCURRENCY PLATFORM KNOWN FOR ITS COMMITMENT TO SECURITY, COMPLIANCE AND INNOVATION. THROUGH THIS PARTNERSHIP, UNIVERSAL DIGITAL WILL LEVERAGE CRYPTO.COM'S ROBUST PLATFORM, WHICH PROVIDES INSTITUTIONAL-GRADE CUSTODY INFRASTRUCTURE AND OVER-THE-COUNTER (OTC) SERVICES, TO SUPPORT THE MANAGEMENT OF THE COMPANY'S PORTFOLIO OF DIGITAL ASSETS.
LFGMF
• Nov. 5, 2025
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ WISHPOND SUBSIDIARY TO BE SPUN-OUT INTO SEPARATE PUBLIC COMPANY TO ENABLE FOCUSED EXPANSION IN AI SALES & MARKETING VANCOUVER, BC , NOV. 5, 2025 /PRNEWSWIRE/ - G2M CAP CORP. (TSXV: GTM) ("G2M"), WISHPOND TECHNOLOGIES LTD. ("WISHPOND") (TSXV: WISH) (OTCQX: WPNDF) AND 1560320 B.C.
WPNDF
• Nov. 5, 2025
SAN JOSE, CALIF. , NOV. 5, 2025 /PRNEWSWIRE/ -- HIPPO HOLDINGS INC. (NYSE: HIPO), A TECHNOLOGY-NATIVE INSURANCE PLATFORM DRIVING GROWTH ACROSS OWNED AND PARTNER MGAS, ANNOUNCED ITS CONSOLIDATED FINANCIAL RESULTS INCLUDING DILUTED NET EARNINGS PER SHARE OF $3.77 AND ADJUSTED EARNINGS PER SHARE OF $0.70 FOR THE QUARTER ENDED SEPTEMBER 30, 2025.
HIPO
• Nov. 5, 2025
LAS VEGAS , NOV. 5, 2025 /PRNEWSWIRE/ -- HYPERSCALE DATA, INC. (NYSE AMERICAN: GPUS), AN ARTIFICIAL INTELLIGENCE ("AI") DATA CENTER COMPANY ANCHORED BY BITCOIN ("HYPERSCALE DATA" OR THE "COMPANY"), TODAY ANNOUNCED THE SUCCESSFUL COMPLETION OF ITS PREVIOUSLY DISCLOSED AT-THE-MARKET ("ATM") EQUITY PROGRAM, STRENGTHENING THE COMPANY'S BALANCE SHEET AND ACCELERATING GROWTH INITIATIVES. THROUGH THE PROGRAM, THE COMPANY SOLD 255,490,454 SHARES OF ITS CLASS A COMMON STOCK FOR GROSS PROCEEDS OF $125 MILLION.
GPUS
• Nov. 5, 2025
TSX: MFI WWW.MAPLELEAFFOODS.COM MAPLE LEAF FOODS REPORTS REVENUE GROWTH OF 8.0% AND TOTAL COMPANY ADJUSTED EBITDA GROWTH OF 21.7% MISSISSAUGA, ON , NOV. 5, 2025 /PRNEWSWIRE/ - MAPLE LEAF FOODS INC ("MAPLE LEAF FOODS" OR THE "COMPANY") (TSX: MFI) TODAY REPORTED ITS FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025. THIRD QUARTER HIGHLIGHTS TOTAL COMPANY (I ) TOTAL COMPANY SALES (II ) WERE $1,356.3 MILLION FOR THE THIRD QUARTER, COMPARED TO $1,255.5 MILLION FOR THE SAME PERIOD LAST YEAR, AN INCREASE OF 8.0%.
MLFNF
• Nov. 5, 2025
CERRITOS, CALIF., NOV. 05, 2025 (GLOBE NEWSWIRE) -- GEN RESTAURANT GROUP, INC. (“GEN” OR THE “COMPANY”) (NASDAQ: GENK), OWNER OF GEN KOREAN BBQ, A FAST-GROWING CASUAL DINING CONCEPT WITH AN EXTENSIVE MENU AND SIGNATURE “GRILL AT YOUR TABLE” EXPERIENCE, WILL HOLD A CONFERENCE CALL ON FRIDAY, NOVEMBER 7, 2025, AT 5:00 P.M.
GENK
• Nov. 5, 2025
NEW YORK--(BUSINESS WIRE)--LEMONADE, INC. (NYSE: LMND) HAS RELEASED ITS THIRD QUARTER 2025 FINANCIAL RESULTS BY POSTING THEM TO ITS WEBSITE. YOU MAY VIEW THE FINANCIAL RESULTS IN THE Q3 2025 LETTER TO SHAREHOLDERS. TODAY, LEMONADE WILL HOST A CONFERENCE CALL AT 8:00 AM EASTERN TIME (5:00 AM PACIFIC TIME) TO DISCUSS THE RESULTS. TO JOIN THE CALL, PLEASE DIAL IN, TOLL-FREE AT (833) 470 1428, OR AT (646) 844 6383; CONFERENCE ID: 547557. TO JOIN THE LIVE WEBCAST PLEASE VISIT THE LEMONADE INVESTOR R.
LMND
• Nov. 5, 2025
LONDON & MILAN--(BUSINESS WIRE)--ARES MANAGEMENT CORPORATION (“ARES”) (NYSE: ARES), A LEADING GLOBAL ALTERNATIVE INVESTMENT MANAGER, ANNOUNCED TODAY THAT ARES ALTERNATIVE CREDIT FUNDS (“ARES ALTERNATIVE CREDIT”) AND OTHER AFFILIATED ARES FUNDS HAVE COMPLETED THE ACQUISITION OF A 20% STAKE IN PLENITUDE, A LEADER IN ENERGY TRANSITION CONTROLLED BY ENI, FOR €2 BILLION AT AN IMPLIED ENTERPRISE VALUE OF OVER €12 BILLION. “THIS CLOSING UNDERSCORES THE ARES PLATFORM'S ABILITY TO DELIVER FLEXIBLE CAPIT.
ARES
• Nov. 5, 2025
GUANGZHOU, CHINA, NOV. 05, 2025 (GLOBE NEWSWIRE) -- WERIDE (NASDAQ: WRD), A GLOBAL LEADER IN AUTONOMOUS DRIVING TECHNOLOGY, TODAY ANNOUNCED THAT ITS ONE-STAGE END-TO-END ADAS (ADVANCED DRIVER ASSISTANCE SYSTEM) SOLUTION, JOINTLY DEVELOPED WITH LEADING TIER 1 SUPPLIER BOSCH, HAS OFFICIALLY ACHIEVED SOP (START OF PRODUCTION). FROM PROJECT LAUNCH TO SOP, WERIDE TOOK JUST SEVEN MONTHS, SETTING A NEW INDUSTRY RECORD AND HIGHLIGHTING ITS DEEP TECHNOLOGICAL EXPERTISE AND EFFICIENT EXECUTION CAPABILITIES IN THE ADAS SECTOR.
WRD
• Nov. 5, 2025
NOVI, MICH.--(BUSINESS WIRE)--LINEAGE, INC. (NASDAQ: LINE) (THE "COMPANY"), THE WORLD'S LARGEST GLOBAL TEMPERATURE-CONTROLLED WAREHOUSE REIT, TODAY ANNOUNCED ITS FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2025. THIRD QUARTER 2025 FINANCIAL HIGHLIGHTS TOTAL REVENUE INCREASED 3.1% TO $1,377 MILLION GAAP NET LOSS OF $(112) MILLION, OR $(0.44) PER DILUTED COMMON SHARE ADJUSTED EBITDA INCREASED 2.4% TO $341 MILLION; ADJUSTED EBITDA MARGIN DECREASED (10) BPS TO 24.8% AFFO INCREASED 6.3% TO $221 MILLI.
LINE
• Nov. 5, 2025
A MEDIA SNIPPET ACCOMPANYING THIS ANNOUNCEMENT IS AVAILABLE BY CLICKING ON THIS LINK.
HKHHY
• Nov. 5, 2025
BEIJING , NOV. 5, 2025 /PRNEWSWIRE/ -- SO-YOUNG INTERNATIONAL INC. (NASDAQ: SY) ("SO-YOUNG" OR THE "COMPANY"), THE LEADING AESTHETIC TREATMENT PLATFORM IN CHINA CONNECTING CONSUMERS WITH ONLINE SERVICES AND OFFLINE TREATMENTS, TODAY ANNOUNCED THAT IT WILL REPORT ITS FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025, BEFORE U.S. MARKETS OPEN ON NOVEMBER 17, 2025. SO-YOUNG'S MANAGEMENT WILL HOLD AN EARNINGS CONFERENCE CALL ON MONDAY, NOVEMBER 17, 2025, AT 7:00 AM U.S. EASTERN TIME (8:00 PM ON THE SAME DAY, BEIJING/HONG KONG TIME).
SY
• Nov. 5, 2025
EARNINGS CALL SCHEDULED FOR 8:30 A.M. U.S. EASTERN TIME ON WEDNESDAY, NOVEMBER 12, 2025 EARNINGS CALL SCHEDULED FOR 8:30 A.M. U.S. EASTERN TIME ON WEDNESDAY, NOVEMBER 12, 2025
INC
• Nov. 5, 2025
VANCOUVER, BRITISH COLUMBIA--(NEWSFILE CORP. - NOVEMBER 5, 2025) - PROVENANCE GOLD CORP. (CSE: PAU) (OTCQB: PVGDF) ("PROVENANCE" OR THE "COMPANY") IS PLEASED TO ANNOUNCE ASSAY RESULTS FROM THE THIRD HOLE OF THE COMPANY'S FIRST STEP-OUT DRILLING IN THE HERMAN AREA AT ITS ELDORADO GOLD PROJECT IN EASTERN OREGON. HIGHLIGHTS ED29: 1.56 G/T AU OVER 254.51 M FROM SURFACE AND ENDING IN MINERALIZATION, INCLUDING 2.84 G/T AU OVER 42.67M INCLUDING 9.8 G/T AU OVER 6.10M NEW MINERALIZED ZONE: 5.94 G/T AU OVER 19.81M INCLUDING 20.33 G/T AU OVER 4.57M HOLE ED29 WAS DRILLED SOUTHWESTWARD FROM THE HERMAN AREA INTO A PREVIOUSLY UNDRILLED REGION, APPROXIMATELY 50M TO THE SOUTH OF ED27 (SEE PRESS RELEASE DATED OCTOBER 8, 2025).
PVGDF
• Nov. 5, 2025
DUBAI, UAE, NOV. 5, 2025 /PRNEWSWIRE/ -- AMBITIONS ENTERPRISE MANAGEMENT CO. L.L.C, ("AMBITIONS" OR "THE COMPANY") (NASDAQ: AHMA), A UAE-BASED MICE (MEETINGS, INCENTIVES, CONFERENCES, AND EXHIBITIONS) AND TOURISM SERVICES PROVIDER, TODAY ANNOUNCED THAT ITS UAE-BASED SUBSIDIARY, MULTIPLE EVENTS L.L.C, SUCCESSFULLY DELIVERED COMPREHENSIVE EVENT MANAGEMENT AND SERVICES FOR THE FLAG HANDOVER CEREMONY AT THE CLOSING BANQUET OF THE 18TH WORLD CHINESE ENTREPRENEURS CONVENTION (WCEC), HELD IN MACAU, CHINA.
AHMA
• Nov. 5, 2025
SINGAPORE , NOV. 5, 2025 /PRNEWSWIRE/ -- TRIP.COM GROUP LIMITED (NASDAQ: TCOM; HKEX: 9961), A LEADING ONE-STOP TRAVEL SERVICE PROVIDER OF ACCOMMODATION RESERVATION, TRANSPORTATION TICKETING, PACKAGED TOURS AND CORPORATE TRAVEL MANAGEMENT, WILL ANNOUNCE ITS FINANCIAL RESULTS FOR THE THREE MONTHS ENDED SEPTEMBER 30, 2025 ON MONDAY, NOVEMBER 17, 2025, U.S. TIME, AFTER THE MARKET CLOSES. TRIP.COM GROUP'S MANAGEMENT TEAM WILL HOST A CONFERENCE CALL AT 7:00 PM U.S. EASTERN TIME ON NOVEMBER 17, 2025 (OR 8:00 AM ON NOVEMBER 18, 2025 IN THE HONG KONG TIME) FOLLOWING THE ANNOUNCEMENT.
TCOM
• Nov. 5, 2025
SHANGHAI , NOV. 5, 2025 /PRNEWSWIRE/ -- AILUX, AN INNOVATOR IN AI-POWERED BIOLOGICS AND A WHOLLY OWNED SUBSIDIARY OF XTALPI (2228.HK), A GLOBAL LEADER IN AI DRUG DISCOVERY, TODAY ANNOUNCED A STRATEGIC PLATFORM-BASED COLLABORATION WITH ELI LILLY AND COMPANY ("LILLY") TO ACCELERATE THE DISCOVERY AND DEVELOPMENT OF BISPECIFIC ANTIBODIES FOR THE TREATMENT OF VARIOUS DISEASES. THROUGH THIS COLLABORATION, LILLY WILL GAIN ACCESS TO AILUX'S AI-POWERED BISPECIFIC ANTIBODY ENGINEERING PLATFORM, WHICH INTEGRATES ADVANCED STRUCTURAL MODELING, GENERATIVE DESIGN, AND DEVELOPABILITY ANALYTICS TO DELIVER THERAPEUTIC CONSTRUCTS WITH NOVEL FUNCTION, OPTIMAL EFFICACY AND DRUG-LIKE PROPERTIES.
LLY
• Nov. 5, 2025
TAIPEI , NOV. 5, 2025 /PRNEWSWIRE/ -- DELTA, A GLOBAL LEADER IN POWER MANAGEMENT AND SMART GREEN SOLUTIONS, ANNOUNCED TODAY IT HAS ACHIEVED THE WORLD'S FIRST ISO 59004 CIRCULAR ECONOMY CERTIFICATION WITHIN THE GLOBAL ICT INDUSTRY. WITH AN EXCEPTIONAL SCORE OF 5 OUT OF 5 IN THE COMPREHENSIVE AUDIT, DELTA DEMONSTRATED A WELL-ENGINEERED, ENTERPRISE-WIDE CIRCULAR ECONOMY MANAGEMENT SYSTEM, ENCOMPASSING KEY ACTIVITIES SUCH AS CIRCULAR PROCUREMENT, DESIGN FOR CIRCULARITY, PROCESS OPTIMIZATION, RESOURCE RECOVERY AND RECYCLING, AND WASTE MANAGEMENT.
DAL
• Nov. 5, 2025
NORTH YORK, ONTARIO, NOV. 05, 2025 (GLOBE NEWSWIRE) -- RUNSTACK INC., A CANADIAN AI-TECH STARTUP BUILDING THE NEXT GENERATION OF AI AGENT INFRASTRUCTURE, TODAY ANNOUNCED ITS OFFICIAL ENTRY INTO THE MARKET. WHILE THE COMPANY'S PRODUCTS ARE NOT YET PUBLICLY AVAILABLE, RUNSTACK REVEALED THAT ITS FORTHCOMING PLATFORM WILL FUNDAMENTALLY CHANGE HOW PEOPLE DEPLOY, COORDINATE, AND SCALE AI AGENTS ACROSS TEAMS, TOOLS, AND DATA ENVIRONMENTS.
META
• Nov. 5, 2025
AUSTIN, TEXAS--(BUSINESS WIRE)--FAL.CON EUROPE, BARCELONA – CROWDSTRIKE (NASDAQ: CRWD) TODAY ANNOUNCED NEW FALCON® FOR XIOT INNOVATIONS, DELIVERING ZERO-TOUCH ASSET DISCOVERY, REAL-TIME SEGMENTATION VISIBILITY, AND UNIFIED INSIGHT ACROSS OT AND XIOT ENVIRONMENTS. THESE INNOVATIONS EXTEND THE PROTECTION OF THE CROWDSTRIKE FALCON® PLATFORM, ELIMINATING BLIND SPOTS AND COMPLEXITY WHILE CONSOLIDATING SECURITY ACROSS IT, CLOUD, AND OT/XIOT ENVIRONMENTS. THE EXPANDING OPERATIONAL ATTACK SURFACE AS IN.
CRWD
• Nov. 5, 2025
5 NOVEMBER 2025 PAYPOINT PLC ("THE COMPANY") NOTIFICATIONS OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES (TOGETHER “PDMRS”) 1. PAYPOINT PLC - SPECIAL DIVIDEND FOLLOWING SHARE CONSOLIDATION THE COMPANY ANNOUNCES THAT THE TRUSTEE OF THE SIP HAS ADVISED THE COMPANY THAT THE PDMRS SET OUT BELOW ON 31 OCTOBER 2025 RECEIVED A SPECIAL DIVIDEND OF 50.0 PENCE PER SHARE IN RESPECT OF SHARES HELD AS AT 17 OCTOBER 2025, AND AS SET OUT IN THE CIRCULAR TO SHAREHOLDERS DATED 30 SEPTEMBER 2025.
PYPTF
• Nov. 5, 2025
NORWICH, ENGLAND--(BUSINESS WIRE)--CADELER, A KEY PARTNER IN OFFSHORE WIND INSTALLATION AND SERVICES, HAS OFFICIALLY OPENED ITS NEW UK OFFICE IN NORWICH, MARKING ANOTHER STEP IN THE COMPANY'S CONTINUED GROWTH AND REINFORCING ITS PRESENCE IN THE UK OFFSHORE WIND MARKET. THE RELOCATION OF CADELER'S UK-BASED TEAM FROM GREAT YARMOUTH TO NORWICH, AND TO A SIGNIFICANTLY LARGER AND MORE MODERN WORKSPACE, IS DESIGNED TO SUPPORT CADELER'S EXPANDING PORTFOLIO OF PROJECTS ACROSS THE UK AND THE REST OF EUR.
CDLR
• Nov. 5, 2025
VODNJAN, CROATIA--(BUSINESS WIRE)--NISSAN HAS REDEFINED CUSTOMER ENGAGEMENT BY PARTNERING WITH GLOBAL CLOUD COMMUNICATIONS PLATFORM INFOBIP TO PIONEER AN AGENTIC AI CAMPAIGN.
NSANY
• Nov. 5, 2025
BEIJING, NOV. 05, 2025 (GLOBE NEWSWIRE) -- SUNLANDS TECHNOLOGY GROUP (NYSE: STG) ("SUNLANDS" OR THE "COMPANY"), A LEADER IN CHINA'S ADULT ONLINE EDUCATION MARKET AND CHINA'S ADULT PERSONAL INTEREST LEARNING MARKET, TODAY ANNOUNCED THAT IT WILL REPORT ITS THIRD QUARTER 2025 UNAUDITED FINANCIAL RESULTS ON THURSDAY, NOVEMBER 20, 2025, BEFORE THE OPEN OF U.S. MARKETS. SUNLANDS' MANAGEMENT TEAM WILL HOST A CONFERENCE CALL AT 7:00 A.M.
STG
• Nov. 5, 2025
ZUG, SWITZERLAND, NOV. 05, 2025 (GLOBE NEWSWIRE) -- OCULIS HOLDING AG (NASDAQ: OCS / XICE: OCS) (“OCULIS”), A GLOBAL BIOPHARMACEUTICAL COMPANY FOCUSED ON BREAKTHROUGH INNOVATIONS TO ADDRESS SIGNIFICANT UNMET MEDICAL NEEDS IN NEURO-OPHTHALMOLOGY AND OPHTHALMOLOGY, ANNOUNCED TODAY THAT OCULIS' MANAGEMENT WILL PARTICIPATE IN UPCOMING INVESTOR CONFERENCES IN NOVEMBER.
OCS
• Nov. 5, 2025
AUSTIN, TEXAS--(BUSINESS WIRE)--FAL.CON EUROPE, BARCELONA – CROWDSTRIKE (NASDAQ: CRWD) TODAY EXPANDED ITS AGENTIC SECURITY WORKFORCE, INTRODUCING NEW MISSION-READY AGENTS THAT EXTEND THE FALCON® PLATFORM AND DRIVE THE EVOLUTION OF THE AGENTIC SOC. BUILDING ON THE FIRST WAVE OF AGENTS INTRODUCED AT FAL.CON 2025, NEW AGENTS BRING AGENTIC AUTOMATION TO COMMON FALCON PLATFORM TASKS SUCH AS APP CREATION AND DATA ONBOARDING, ACCELERATING OUTCOMES AND LIBERATING ANALYSTS TO FOCUS ON THE STRATEGIC DECI.
CRWD
• Nov. 5, 2025
AUSTIN, TEXAS--(BUSINESS WIRE)--FAL.CON EUROPE, BARCELONA – CROWDSTRIKE (NASDAQ: CRWD) TODAY ANNOUNCED CHARLOTTE AGENTIC SOAR, THE ORCHESTRATION LAYER OF THE FALCON AGENTIC SECURITY PLATFORM. CHARLOTTE AGENTIC SOAR ORCHESTRATES AI-POWERED AGENTS ACROSS THE SECURITY LIFECYCLE, CONNECTING CONTEXT AND DATA SO THEY CAN REASON AND ACT DYNAMICALLY TOGETHER IN REAL TIME UNDER ANALYST COMMAND. BY UNITING NATIVE, CUSTOM-BUILT, AND TRUSTED THIRD-PARTY AGENTS IN A SINGLE COORDINATED SYSTEM, CHARLOTTE AGEN.
CRWD
• Nov. 5, 2025
CALGARY, ALBERTA--(BUSINESS WIRE)--E3 LITHIUM LTD. (TSXV: ETL) (FSE: OW3) (OTCQX: EEMMF), (“E3 LITHIUM” OR THE “COMPANY”) A LEADER IN CANADIAN LITHIUM DEVELOPMENT, REMINDS SHAREHOLDERS AND INTERESTED STAKEHOLDERS THE COMPANY IS HOSTING A WEBINAR THIS MORNING, NOVEMBER 5, 2025, AT 9:00AM MT. DURING THE PRESENTATION, CHRIS DOORNBOS, PRESIDENT AND CEO, AND MEMBERS OF THE E3 LITHIUM MANAGEMENT TEAM WILL DISCUSS: SUMMARY OF PHASE 1 DEMONSTRATION FACILITY ACHIEVEMENTS UPDATE ON PHASE 2 DEMONSTRATION.
LTUM
• Nov. 5, 2025
POINT COMPLETES ITS SIXTH RATED SECURITIZATION, THE LARGEST BOND ISSUANCE IN THE HOME EQUITY INVESTMENT SPACE TO DATE, SIGNALING FURTHER MATURATION OF THE ASSET CLASS POINT COMPLETES ITS SIXTH RATED SECURITIZATION, THE LARGEST BOND ISSUANCE IN THE HOME EQUITY INVESTMENT SPACE TO DATE, SIGNALING FURTHER MATURATION OF THE ASSET CLASS
OWL
• Nov. 5, 2025
THE REPORT REVEALS 239 MALICIOUS PLAY APPS WITH OVER 42M USER INSTALLS THE REPORT REVEALS 239 MALICIOUS PLAY APPS WITH OVER 42M USER INSTALLS
ZS
• Nov. 5, 2025
HONG KONG, NOV. 05, 2025 (GLOBE NEWSWIRE) -- FUTU HOLDINGS LIMITED (“FUTU” OR THE “COMPANY”) (NASDAQ: FUTU), A LEADING TECH-DRIVEN ONLINE BROKERAGE AND WEALTH MANAGEMENT PLATFORM, TODAY ANNOUNCED THAT IT WILL REPORT ITS FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025, BEFORE U.S. MARKETS OPEN ON NOVEMBER 18, 2025.
FUTU
• Nov. 5, 2025
MAJOR CUSTOMER RENEWAL, GLOBAL EXPANSION, AND NEW INNOVATIONS POSITION CORERO FOR CONTINUED GROWTH INTO 2026 LONDON , NOV. 5, 2025 /PRNEWSWIRE/ -- CORERO NETWORK SECURITY (AIM: CNS) (OTCQX: DDOSF), A RECOGNIZED LEADER IN DDOS PROTECTION AND CHAMPION OF ADAPTIVE, REAL-TIME SERVICE AVAILABILITY, TODAY REPORTED ACCELERATING GLOBAL GROWTH IN Q3 2025, FUELED BY RISING ORDER INTAKE AND CONTINUED INNOVATION ACROSS ITS SMARTWALL ONE™ PLATFORM, AND BEGAN Q4 WITH A MAJOR RENEWAL AND EXPANSION WITH A LEADING US CLOUD COMPUTING PROVIDER. BUILDING ON STRONG EXECUTION, CORERO ACHIEVED $7.4 MILLION IN Q3 ORDER INTAKE (UP FROM $6.0 MILLION IN Q3 2024) WITH NEW CUSTOMER WINS SPANNING THE US, UK, EUROPE, BRAZIL, AND SINGAPORE.
CNS
• Nov. 5, 2025
STOCKHOLM , NOV. 5, 2025 /PRNEWSWIRE/ -- MOBERG PHARMA AB (PUBL) HAS ENTERED INTO AN EXCLUSIVE LICENSING AGREEMENT WITH KARO HEALTHCARE AB REGARDING THE COMMERCIALIZATION OF MOB-015 (TERCLARA®) IN EUROPE. THE AGREEMENT COMPRISES 19 EUROPEAN MARKETS, ENABLING A COORDINATED LAUNCH ACROSS ALL KEY EU MARKETS UNDER THE LEADING GLOBAL ANTIFUNGAL BRAND LAMISIL®.
MBGPF
• Nov. 5, 2025
VANCOUVER, BRITISH COLUMBIA--(NEWSFILE CORP. - NOVEMBER 5, 2025) - KINGMAN MINERALS LTD. (TSXV: KGS) (OTCQB: KGSSF) (FSE: 47A) ("KINGMAN" OR THE "COMPANY") IS PLEASED TO UPDATE SHAREHOLDERS ON THE SIGNIFICANT PROGRESS TO DATE AT ITS FLAGSHIP MOHAVE PROJECT IN MOHAVE COUNTY, ARIZONA, WHICH INCLUDES THE HISTORIC ROSEBUD MINE.
KGSSF
• Nov. 5, 2025
SHANGHAI , NOV. 5, 2025 /PRNEWSWIRE/ -- CHINA PETROLEUM & CHEMICAL CORPORATION (HKG: 0386, "SINOPEC") HOSTED A THEMED FORUM AND A SIGNING CEREMONY ON NOVEMBER 4 AT THE 8TH CHINA INTERNATIONAL IMPORT EXPO (CIIE 2025). THE COMPANY SIGNED PURCHASING CONTRACTS WITH 34 PARTNERS FROM 17 COUNTRIES AND REGIONS, WHICH TOTALED US$40.9 BILLION, INCLUDING 24 PRODUCTS FROM 10 MAJOR CATEGORIES, INCLUDING CRUDE OIL, CHEMICALS, EQUIPMENT, MATERIALS, CONSUMER GOODS AND MORE.
SNPMF
• Nov. 5, 2025
PALO ALTO, CALIF.--(BUSINESS WIRE)--GUARDANT HEALTH, INC. (“GUARDANT HEALTH”) (NASDAQ: GH), A LEADING PRECISION ONCOLOGY COMPANY, TODAY ANNOUNCED THE PRICING OF AN UPSIZED UNDERWRITTEN PUBLIC OFFERING OF 3,333,333 SHARES OF GUARDANT HEALTH'S COMMON STOCK AT A PUBLIC OFFERING PRICE OF $90.00 PER SHARE (THE “COMMON STOCK OFFERING”). THE SIZE OF THE COMMON STOCK OFFERING WAS INCREASED FROM THE PREVIOUSLY ANNOUNCED $250.0 MILLION OF SHARES OF COMMON STOCK. IN ADDITION, GUARDANT HEALTH GRANTED THE U.
GH
• Nov. 5, 2025
PALO ALTO, CALIF.--(BUSINESS WIRE)--GUARDANT HEALTH, INC. (“GUARDANT HEALTH”) (NASDAQ: GH), A LEADING PRECISION ONCOLOGY COMPANY, TODAY ANNOUNCED THE PRICING OF ITS UPSIZED OFFERING OF $350.0 MILLION AGGREGATE PRINCIPAL AMOUNT OF 0% CONVERTIBLE SENIOR NOTES DUE 2033 (THE “NOTES”) IN A PRIVATE OFFERING (THE “CONVERTIBLE NOTES OFFERING”) TO PERSONS REASONABLY BELIEVED TO BE QUALIFIED INSTITUTIONAL BUYERS PURSUANT TO RULE 144A UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). TH.
GH
• Nov. 5, 2025
NEW YORK , NOV. 5, 2025 /PRNEWSWIRE/ -- ONASSIS HOLDING CORP (OTC: ONSS) A US PUBLIC COMPANY PIONEERING CELLULAR REJUVENATION AND LONGEVITY BIOTECHNOLOGY, IS PLEASED TO ANNOUNCE THE APPOINTMENT OF ESQ. PAZ ITZHAKI-WEINBERGER TO ITS ADVISORY BOARD.
ONSS
• Nov. 5, 2025
UXBRIDGE, ENGLAND / ACCESS NEWSWIRE / NOVEMBER 5, 2025 / TRADING UPDATE FOR THE THIRD QUARTER ENDED 26 SEPTEMBER 2025 & INTERIM DIVIDEND DECLARATION SOLID THIRD QUARTER; REAFFIRMING FULL-YEAR GUIDANCE CHANGE VS 2024 REVENUE VOLUME (UC)[2] REVENUE PER UC[1],[2],[3] COMPARABLE VOLUME[1] REVENUE PER UC[1],[2],[3] FXN[1],[3] REVENUE REVENUE Q3 2025 EUROPE €4,194M 701M €6.01 0.9% 3.4% 4.2% 3.8% APS €1,216M 311M €4.23 (0.6)% 0.3% (0.2)% (7.7)% CCEP €5,410M 1,012M €5.46 0.4% 2.7% 3.2% 1.0% YTD 2025 EUROPE €11,665M 1,947M €5.99 0.1% 3.9% 3.0% 3.1% APS €4,019M 997M €4.23 11.5% (1.6)% 9.1% 3.9% CCEP €15,684M 2,944M €5.39 3.7% 1.7% 4.5% 3.3% CHANGE VS 2024 ADJUSTED COMPARABLE REVENUE[4] ADJUSTED COMPARABLE VOLUME (UC)[4] ADJUSTED COMPARABLE REVENUE PER UC[4] ADJUSTED COMPARABLE VOLUME[4] ADJUSTED COMPARABLE REVENUE PER UC[4] ADJUSTED COMPARABLE FXN REVENUE[4] ADJUSTED COMPARABLE REVENUE[4] Q3 2025 EUROPE €4,194M 701M €6.01 0.9% 3.4% 4.2% 3.8% APS €1,216M 311M €4.23 (0.6)% 0.3% (0.2)% (7.7)% CCEP €5,410M 1,012M €5.46 0.4% 2.7% 3.2% 1.0% YTD 2025 EUROPE €11,665M 1,947M €5.99 0.1% 3.9% 3.0% 3.1% APS €4,019M 997M €4.23 0.8% 2.3% 2.1% (2.8)% CCEP €15,684M 2,944M €5.39 0.3% 3.4% 2.7% 1.5% DAMIAN GAMMELL, CHIEF EXECUTIVE OFFICER, SAID: "2025 CONTINUES TO BE A SOLID YEAR FOR CCEP, REFLECTING OUR GREAT BRANDS, GREAT PEOPLE, GREAT EXECUTION AND STRONG RELATIONSHIPS WITH OUR BRAND PARTNERS AND CUSTOMERS. WE'VE DELIVERED ANOTHER QUARTER OF VOLUME GROWTH IN EUROPE, DESPITE SOFTER CONSUMER DEMAND.
PGPHF
• Nov. 5, 2025
CELLBXHEALTH PRESENTS PROOF-OF-CONCEPT STUDY USING ROCHE TISSUE DIAGNOSTICS' WORKFLOW AT WORLD-LEADING DRUG DEVELOPMENT CONFERENCE PARSORTIX PLATFORM SHOWN TO BE COMPATIBLE WITH THE ROCHE BENCHMARK ULTRA AUTOMATED STAINING SYSTEM, WITH INITIAL STUDY OF THREE KEY DRUG TARGETS: HER2 (BREAST), TROP2 (LUNG) AND PSMA (PROSTATE) GUILFORD, SURREY AND PLYMOUTH MEETING, PA / ACCESS NEWSWIRE / NOVEMBER 5, 2025 / CELLBXHEALTH PLC (AIM:CLBX)(OTCQX:ANPCY), A GLOBAL LEADER IN CIRCULATING TUMOUR CELL (CTC) INTELLIGENCE, ANNOUNCES THE PRESENTATION OF A PROOF-OF-CONCEPT STUDY USING A ROCHE TISSUE DIAGNOSTICS WORKFLOW AT THE 16TH WORLD ADC CONFERENCE, SAN DIEGO, USA (NOV 3-6). THE WORLD ADC CONFERENCE IS THE LARGEST GLOBAL EVENT DEDICATED TO ANTIBODY-DRUG CONJUGATES (ADCS), ATTRACTING OVER 1,400 ATTENDEES FOCUSED ON ADVANCING TARGETED CANCER THERAPIES.
PLC
• Nov. 5, 2025
GROUP REVENUES OF € 535.1 M ((7.1)%); DISCOVERY & PRECLINICAL DEVELOPMENT SEGMENT ("D&PD", (12.3)%) STILL SEES SOFT DEMAND;JUST - EVOTEC BIOLOGICS ("JEB"; +11.3%) ABOVE-EXPECTATION; FURTHER ACCELERATING GROWTH ON NON-SANDOZ / NON-DOD BUSINESS STRONG SCIENTIFIC ADVANCEMENTS OF CO-DEVELOPED ASSET PIPELINE: EXPECTING UP TO FOUR MOLECULES IN CLINICAL PHASE II IN NEXT SIX TO NINE MONTHS SIGNING OF LANDMARK INDUSTRY TRANSACTION WITH SANDOZ ON 04 NOVEMBER, RESULTING IN PAYMENTS POTENTIALLY OVER US$ 650 M PLUS ROYALTIES ON PORTFOLIO OF UP TO 10 BIOSIMILAR MOLECULES 2025 GUIDANCE AND 2028 OUTLOOK CONFIRMED HAMBURG, DE / ACCESS NEWSWIRE / NOVEMBER 5, 2025 / EVOTEC SE (FRANKFURT STOCK EXCHANGE: EVT, SDAX/TECDAX, PRIME STANDARD, ISIN: DE0005664809, WKN 566480; NASDAQ: EVO) TODAY ANNOUNCED ITS BUSINESS UPDATE FOR 9M 2025, ILLUSTRATING THE ONGOING SYSTEMATIC EXECUTION OF ITS STRATEGY. IN THE D&PD SEGMENT, THE MARKET FOR EARLY DRUG DISCOVERY SERVICES REMAINED SOFT, WHILE STRATEGIC PARTNERSHIPS ARE ON TRACK AND EVOTEC RECORDS STRONG PROGRESS IN ITS PARTNERED ASSET PIPELINE.
SDZNY
• Nov. 5, 2025
SANTA CLARA, CALIF.--(BUSINESS WIRE)---- $ACHR #ARCHER--TODAY ARCHER AVIATION INC. (NYSE: ACHR) ANNOUNCED THE JAPAN AIRLINES-LED CONSORTIUM, WHICH FEATURES ARCHER'S MIDNIGHT AIRCRAFT, WAS SELECTED BY THE TOKYO METROPOLITAN GOVERNMENT TO PARTICIPATE IN PHASE ONE OF TOKYO'S “EVTOL IMPLEMENTATION PROJECT.” PHASE ONE OF THE PROJECT WILL ASSESS THE MARKET AND BUILD THE OPERATING ECOSYSTEM, LEADING UP TO PLANNED DEMONSTRATION FLIGHTS OVER TOKYO BAY AND RIVER ROUTES, WHICH REPRESENTS CRITICAL STEPS TOWARDS RAMPING COMM.
ACHR
• Nov. 5, 2025
LONDON, 5 NOVEMBER 2025- LIFT BIOSCIENCES, ('LIFT' OR 'THE COMPANY'), A RAPIDLY EMERGING BIOTECH AND THE GLOBAL LEADER IN NEUTROPHIL IMMUNOTHERAPIES, TODAY ANNOUNCES THAT PRECLINICAL DATA DEMONSTRATING THE POTENTIAL OF ITS FIRST-IN-CLASS IMMUNOMODULATORY ALPHA NEUTROPHILS (IMANS) TO RESTORE INNATE IMMUNE COMPETENCE AND REMODEL THE TUMOUR MICROENVIRONMENT (TME) IN SUPPORT OF ANTI-TUMOR IMMUNITY, WILL BE PRESENTED IN A POSTER AT THE 40TH SOCIETY FOR IMMUNOTHERAPY OF CANCER BEING HELD FROM 5-9 NOVEMBER IN NATIONAL HARBOR, MARYLAND.
• Nov. 5, 2025
WOLTERS KLUWER 2025 NINE-MONTH TRADING UPDATE ALPHEN AAN DEN RIJN, NOVEMBER 5, 2025 – WOLTERS KLUWER, A GLOBAL LEADER IN PROFESSIONAL INFORMATION SOLUTIONS, SOFTWARE AND SERVICES, TODAY RELEASES ITS SCHEDULED 2025 NINE-MONTH TRADING UPDATE. HIGHLIGHTS FULL-YEAR 2025 GUIDANCE REAFFIRMED.
WTKWY
• Nov. 5, 2025
AUSTIN, NOV. 05, 2025 (GLOBE NEWSWIRE) -- HORTICULTURE LIGHTING MARKET SIZE AND GROWTH INSIGHTS: ACCORDING TO THE SNS INSIDER,"THE HORTICULTURE LIGHTING MARKET SIZE WAS VALUED AT USD 4. 60 BILLION IN 2024 AND IS EXPECTED TO REACH USD 23. 08 BILLION BY 2032, GROWING AT A CAGR OF 22.
• Nov. 5, 2025
ST HELIER, JERSEY, NOV. 05, 2025 (GLOBE NEWSWIRE) -- (NYSE AMERICAN, AIM AND VFEX: CMCL) - CALEDONIA MINING CORPORATION PLC ("CALEDONIA" OR "THE COMPANY") IS PLEASED TO ANNOUNCE THE APPOINTMENT OF MR JULY NDLOVU TO THE BOARD OF DIRECTORS OF THE COMPANY (“THE BOARD”) AS AN INDEPENDENT NON-EXECUTIVE DIRECTOR.
CMCL
• Nov. 5, 2025
VANCOUVER, BC / ACCESS NEWSWIRE / NOVEMBER 5, 2025 / GANDER GOLD CORPORATION ("GANDER" OR THE "COMPANY") (CSE:GAND)(OTCQB:GANDF), ANNOUNCES THAT THE BRITISH COLUMBIA SECURITIES COMMISSION ("BCSC") HAS ISSUED A FAILURE-TO-FILE CEASE TRADE ORDER ("FFCTO") DATED NOVEMBER 3, 2025, PURSUANT TO MULTILATERAL INSTRUMENT 11-103 - FAILURE-TO-FILE CEASE TRADE ORDERS IN MULTIPLE JURISDICTIONS . THE FFCTO WAS ISSUED AS A RESULT OF THE COMPANY'S FAILURE TO FILE THE FOLLOWING PERIODIC DISCLOSURE DOCUMENTS FOR THE FINANCIAL YEAR ENDED JUNE 30, 2025: ANNUAL AUDITED FINANCIAL STATEMENTS; ANNUAL MANAGEMENT'S DISCUSSION AND ANALYSIS ("MD&A"); AND CERTIFICATION OF ANNUAL FILINGS.
GANDF
• Nov. 5, 2025
VANCOUVER, BC / ACCESS NEWSWIRE / NOVEMBER 5, 2025 / SASSY GOLD CORP. (CSE:SASY)(OTCQB:SSYRF)(FSE:4E7) ("SASSY" OR "THE COMPANY") ANNOUNCES THAT THE BRITISH COLUMBIA SECURITIES COMMISSION ("BCSC") HAS ISSUED A FAILURE-TO-FILE CEASE TRADE ORDER ("FFCTO") DATED NOVEMBER 3, 2025, PURSUANT TO MULTILATERAL INSTRUMENT 11-103 - FAILURE-TO-FILE CEASE TRADE ORDERS IN MULTIPLE JURISDICTIONS. THE FFCTO WAS ISSUED AS A RESULT OF THE COMPANY'S FAILURE TO FILE THE FOLLOWING PERIODIC DISCLOSURE DOCUMENTS FOR THE FINANCIAL YEAR ENDED JUNE 30, 2025: ANNUAL AUDITED FINANCIAL STATEMENTS; ANNUAL MANAGEMENT'S DISCUSSION AND ANALYSIS ("MD&A"); AND CERTIFICATION OF ANNUAL FILINGS.
SSYRF
• Nov. 5, 2025
BAGSVÆRD, 5 NOVEMBER, 2025 - FINANCIAL REPORT FOR THE PERIOD 1 JANUARY 2025 TO 30 SEPTEMBER 2025 OPERATING PROFIT INCREASED BY 5% IN DANISH KRONER AND 10% AT CONSTANT EXCHANGE RATES (CER) TO DKK 95.9 BILLION, IMPACTED BY ONE-OFF RESTRUCTURING COSTS OF AROUND DKK 9 BILLION RELATED TO THE COMPANY-WIDE TRANSFORMATION WITH THE AIM OF STREAMLINING NOVO NORDISK'S OPERATIONS TO REINVEST FOR GROWTH. HAD NOVO NORDISK NOT INCURRED SUCH RESTRUCTURING COSTS AMOUNTING TO AROUND DKK 9 BILLION, OPERATING PROFIT WOULD HAVE INCREASED BY 15% IN DANISH KRONER AND 21% AT CER.
NVO
• Nov. 5, 2025
HIGHLIGHTS PROPORTIONATE POWER GENERATION AMOUNTED TO 574 GWH FOR THE REPORTING PERIOD, WITH ADDITIONAL 30 GWH OF COMPENSATED VOLUMES FROM ANCILLARY SERVICES AND AVAILABILITY WARRANTIES, BRINGING THE TOTAL PROPORTIONATE POWER GENERATION, INCLUDING THESE VOLUMES, TO 604 GWH. THE COMPANY NOW EXPECTS FULL-YEAR 2025 PROPORTIONATE POWER GENERATION, INCLUDING COMPENSATED VOLUMES, TO BE BETWEEN 850 AND 900 GWH.
LNEGY
• Nov. 5, 2025
MARSEILLE, FRANCE--(BUSINESS WIRE)-- #IMMUNOTHERAPY--REGULATORY NEWS: INNATE PHARMA SA (EURONEXT PARIS: IPH; NASDAQ: IPHA) (“INNATE” OR THE “COMPANY”) TODAY ANNOUNCED THAT THE COMPANY WILL HOLD A CONFERENCE CALL ON THURSDAY, NOVEMBER 13, 2025, AT 2 P.M. CET / 8 A.M. ET, TO GIVE AN UPDATE ON BUSINESS PROGRESS DURING THE THIRD QUARTER OF 2025. PARTICIPANTS DURING THE CALL WILL BE: JONATHAN DICKINSON, CHIEF EXECUTIVE OFFICER SONIA QUARATINO, EXECUTIVE VICE PRESIDENT, CHIEF MEDICAL OFFICER YANNIS MOREL, EXECUTIVE V.
IPHA
• Nov. 5, 2025
THE NETHERLANDS, 5 NOVEMBER 2025 VOPAK REPORTS STRONG PERFORMANCE, DRIVEN BY A RESILIENT PORTFOLIO KEY HIGHLIGHTS IMPROVE NET PROFIT -INCLUDING EXCEPTIONAL ITEMS- INCREASED YTD Q3 2025 BY 30% TO EUR 407 MILLION AND EPS OF EUR 3.51 INCREASED BY 37% YEAR-ON-YEAR PROPORTIONAL EBITDA -EXCLUDING EXCEPTIONAL ITEMS1- YTD Q3 2025 OF EUR 902 MILLION AN INCREASE OF 1% YEAR-ON-YEAR, ABSORBING NEGATIVE CURRENCY IMPACT OF EUR 18 MILLION YEAR-TO-DATE PROPORTIONAL OPERATING FREE CASH FLOW PER SHARE YTD Q3 2025 INCREASED BY 4% YEAR-ON-YEAR TO EUR 5.56 PER SHARE REFLECTING STRONG CASH FLOW GENERATION AND BENEFITS OF THE SHARE BUYBACK PROGRAMS IN 2024 AND 2025 CONFIRMING FY 2025 OUTLOOK DRIVEN BY CONTINUED STRONG AND RESILIENT PORTFOLIO PERFORMANCE, OFFSETTING NEGATIVE CURRENCY TRANSLATION EFFECTS GROW INVESTING IN ADDITIONAL THROUGHPUT CAPACITY IN REEF LPG TERMINAL IN CANADA, ADDRESSING HIGH DEMAND FOR ADDITIONAL EXPORT CAPACITY BY INVESTING EUR 34 MILLION EXPANDING INDUSTRIAL CAPACITY IN CAOJING AND HAITENG TERMINALS IN CHINA, STRENGTHENING OUR LEADING INDUSTRIAL POSITION EXPANDING LNG REGASIFICATION CAPACITY AT SPEC TERMINAL IN COLOMBIA BY INVESTING EUR 25 MILLION AVTL ANNOUNCED INVESTMENT DECISION TO BUILD A GREENFIELD GAS TERMINAL (LPG) AT JPNA PORT IN MUMBAI, INDIA AND PROPOSED TO ACQUIRE 75% OF THE SHARES OF HINDUSTAN AEGIS LPG LTD 60% OF THE PROPORTIONAL EUR 2.6 BILLION ALLOCATED TO GROW IN GAS AND INDUSTRIAL TERMINALS COMMITTED SINCE JUNE 2022 ACCELERATE SIGNED A JOINT VENTURE AGREEMENT WITH OQ IN OMAN, TO DEVELOP AND OPERATE ENERGY STORAGE AND TERMINAL INFRASTRUCTURE IN THE STRATEGIC LOCATION OF DUQM Q3 2025 Q2 2025 Q3 2024 IN EUR MILLIONS YTD Q3 2025 YTD Q3 2024 IFRS MEASURES -INCLUDING EXCEPTIONAL ITEMS- 321.6 322.6 325.0 REVENUES 973.1 978.7 87.9 218.8 99.3 NET PROFIT / (LOSS) ATTRIBUTABLE TO HOLDERS OF ORDINARY SHARES 406.5 311.8 0.77 1.89 0.83 EARNINGS PER ORDINARY SHARE (IN EUR) 3.51 2.56 258.5 189.9 219.4 CASH FLOWS FROM OPERATING ACTIVITIES (GROSS) 754.3 737.3 - 141.9 -159.1 -111.0 CASH FLOWS FROM INVESTING ACTIVITIES (INCLUDING DERIVATIVES) - 438.5 -375.3 ALTERNATIVE PERFORMANCE MEASURES -EXCLUDING EXCEPTIONAL ITEMS- 1 467.3 493.7 479.1 PROPORTIONAL REVENUES 1,449.4 1,432.5 286.5 315.4 294.1 PROPORTIONAL GROUP OPERATING PROFIT / (LOSS) BEFORE DEPRECIATION AND AMORTIZATION (EBITDA) 901.8 893.5 226.8 254.8 233.3 GROUP OPERATING PROFIT / (LOSS) BEFORE DEPRECIATION AND AMORTIZATION (EBITDA) 717.8 720.4 89.0 117.1 97.5 NET PROFIT / (LOSS) ATTRIBUTABLE TO HOLDERS OF ORDINARY SHARES 303.9 324.1 0.78 1.01 0.83 EARNINGS PER ORDINARY SHARE (IN EUR) 2.63 2.67 BUSINESS KPIS 35.8 35.8 35.2 STORAGE CAPACITY END OF PERIOD (IN MILLION CBM) 35.8 35.2 20.4 20.4 20.3 PROPORTIONAL STORAGE CAPACITY END OF PERIOD (IN MILLION CBM) 20.4 20.3 91% 91% 92% SUBSIDIARY OCCUPANCY RATE 91% 92% 90% 91% 92% PROPORTIONAL OCCUPANCY RATE 91% 92% FINANCIAL KPIS 1 14.7% 17.0% 15.1% PROPORTIONAL OPERATING CASH RETURN 16.2% 16.2% 2,679.6 2,735.8 2,574.9 NET INTEREST-BEARING DEBT 2,679.6 2,574.9 2.49 2.54 2.28 TOTAL NET DEBT : EBITDA 2.49 2.28 1.68 1.93 1.70 PROPORTIONAL OPERATING FREE CASH FLOW PER SHARE (IN EUR) 5.56 5.33 2.56 2.65 2.60 PROPORTIONAL LEVERAGE 2.56 2.60 CEO MESSAGE WE CONTINUED TO EXECUTE OUR STRATEGY AND ARE REPORTING STRONG RESULTS YEAR-TO-DATE. DEMAND FOR OUR SERVICES REMAINED STRONG RESULTING IN AN INCREASED PROPORTIONAL EBITDA COMPARED TO THE SAME PERIOD LAST YEAR.
VOPKY
• Nov. 5, 2025
PRATTELN, SCHWEIZ, 5. NOVEMBER 2025 - SANTHERA PHARMACEUTICALS (SIX: SANN) GIBT DAS CLOSING DER LIZENZGEBÜHRENVEREINBARUNG ÜBER 13 MILLIONEN US-DOLLAR BEKANNT, DIE ERSTMALS IM SEPTEMBER 2025 ANGEKÜNDIGT WURDE UND DIE WELTWEITE MARKTEINFÜHRUNG VON AGAMREE (VAMOROLONE) UNTERSTÜTZEN SOLL. DIE VEREINBARUNG WURDE URSPRÜNGLICH IM SEPTEMBER 2025 MIT R-BRIDGE, EINER TOCHTERGESELLSCHAFT DER CBC GROUP, GESCHLOSSEN UND UMFASST 25% DER NETTO-LIZENZGEBÜHREN FÜR AGAMREE VON CATALYST PHARMACEUTICALS, INC.
• Nov. 5, 2025
PRATTELN, SWITZERLAND, NOVEMBER 5, 2025 - SANTHERA PHARMACEUTICALS (SIX: SANN) ANNOUNCES THE CLOSING OF A USD 13 MILLION ROYALTY MONETIZATION AGREEMENT, FIRST ANNOUNCED IN SEPTEMBER 2025, TO SUPPORT THE GLOBAL LAUNCHES OF AGAMREE (VAMOROLONE). THE AGREEMENT WAS INITIALLY SECURED IN SEPTEMBER 2025 WITH R-BRIDGE, AN AFFILIATE OF CBC GROUP, COVERING 25% OF NET ROYALTIES ON AGAMREE FROM CATALYST PHARMACEUTICALS, INC.
• Nov. 5, 2025
NEW YORK, NOV. 05, 2025 (GLOBE NEWSWIRE) -- FIVERR INTERNATIONAL LTD. (NYSE: FVRR), THE COMPANY THAT IS TRANSFORMING THE WAY THE WORLD CREATES AND WORKS TOGETHER, TODAY REPORTED FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2025. ADDITIONAL OPERATING RESULTS AND MANAGEMENT COMMENTARY CAN BE FOUND IN THE COMPANY'S SHAREHOLDER LETTER, WHICH IS POSTED TO ITS INVESTOR RELATIONS WEBSITE AT INVESTORS.FIVERR.COM .
FVRR
• Nov. 5, 2025
COPENHAGEN, NOV. 05, 2025 (GLOBE NEWSWIRE) -- UNDER THE NEW AGREEMENT, ISS WILL DELIVER A COMPREHENSIVE RANGE OF SERVICES ACROSS BRISBANE AIRPORT'S DOMESTIC AND INTERNATIONAL TERMINALS, INCLUDING PASSENGER AND BAGGAGE SCREENING, AIRSIDE AND LANDSIDE PATROLS, INSPECTIONS, CCTV MONITORING AND RESPONSE, AND PRECINCT SECURITY.
• Nov. 5, 2025
THE BOARD OF MOWI ASA HAS RESOLVED ON 4 NOVEMBER 2025 TO MAKE A QUARTERLY DISTRIBUTION TO SHAREHOLDERS OF NOK 1.50 PER SHARE. MOWI ASA'S SHARES LISTED ON THE OSLO STOCK EXCHANGE WILL BE TRADED INCLUDING DIVIDEND UP TO AND INCLUDING 13 NOVEMBER 2025.
MHGVY
• Nov. 5, 2025
LUXEMBOURG, LU / ACCESS NEWSWIRE / NOVEMBER 5, 2025 / TERNIUM S.A. (NYSE:TX) ANNOUNCED TODAY THAT ITS SUBSIDIARY TERNIUM INVESTMENTS S.
TX
• Nov. 5, 2025
DXC RECEIVES 16 AWARDS GLOBALLY FROM ISG'S ASSESSMENT OF AWS PARTNERS ASHBURN, VA. , NOV. 5, 2025 /PRNEWSWIRE/ - DXC TECHNOLOGY (NYSE: DXC), A LEADING FORTUNE 500 GLOBAL TECHNOLOGY SERVICES PROVIDER, HAS BEEN NAMED A LEADER BY ISG, A LEADING GLOBAL TECHNOLOGY RESEARCH AND ADVISORY FIRM, IN ITS ISG PROVIDER LENS® AWS ECOSYSTEM PARTNERS STUDY ACROSS THE US, APAC, GERMANY, AND THE UK.
DXC
• Nov. 5, 2025
NEW PSAS FOR SKILLS-FIRST HIRING CAMPAIGN HIGHLIGHT THE COMPETITIVE ADVANTAGE OF HIRING STARS - WORKERS SKILLED THROUGH ALTERNATIVE ROUTES NEW YORK , NOV. 5, 2025 /PRNEWSWIRE/ -- BUILDING ON THE MEASURABLE SUCCESS OF THE FIRST "TEAR THE PAPER CEILING" LAUNCH IN 2022, THE AD COUNCIL AND OPPORTUNITY@WORK TODAY UNVEILED NEW PUBLIC SERVICE ADVERTISEMENTS (PSAS), TITLED "STORY UNFOLD," ENCOURAGING EMPLOYERS TO EMBRACE SKILLS-FIRST HIRING PRACTICES AND ACCESS OVERLOOKED TALENT. RESEARCH FROM LINKEDIN SHOWS THAT HIRING MANAGERS WHO START WITH SKILLS ARE 60% MORE LIKELY TO FIND A SUCCESSFUL HIRE.
EIG
• Nov. 5, 2025
THE WOODLANDS, TEXAS--(BUSINESS WIRE)--AS NOTED IN THE PRESS RELEASE DATED OCTOBER 23, 2025, KODIAK GAS SERVICES, INC. (NYSE: KGS), (“KODIAK” OR THE “COMPANY”) WILL HOST A CONFERENCE CALL AND WEBCAST TO DISCUSS THIRD QUARTER 2025 FINANCIAL RESULTS ON WEDNESDAY, NOVEMBER 5, 2025 AT 11:00 A.M. EASTERN TIME (10:00 A.M. CENTRAL TIME). THE CALL AND WEBCAST MAY BE ACCESSED BY DIALING 877-407-4012 AND ASKING FOR THE KODIAK GAS SERVICES CALL AT LEAST 10 MINUTES PRIOR TO THE START TIME, OR BY ACCESSING.
KGS
• Nov. 4, 2025
NEW YORK AND NEW ORLEANS, NOV. 04, 2025 (GLOBE NEWSWIRE) -- KAHN SWICK & FOTI, LLC (“KSF”) AND KSF PARTNER, FORMER ATTORNEY GENERAL OF LOUISIANA, CHARLES C. FOTI, JR., REMIND INVESTORS THAT THEY HAVE UNTIL DECEMBER 8, 2025 TO FILE LEAD PLAINTIFF APPLICATIONS IN A SECURITIES CLASS ACTION LAWSUIT AGAINST WPP PLC (NYSE: WPP), IF THEY PURCHASED OR OTHERWISE ACQUIRED THE COMPANY'S SHARES BETWEEN FEBRUARY 27, 2025 AND JULY 8, 2025, INCLUSIVE (THE “CLASS PERIOD”). THIS ACTION IS PENDING IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK.
WPP
• Nov. 4, 2025
NEW YORK AND NEW ORLEANS, NOV. 04, 2025 (GLOBE NEWSWIRE) -- KAHN SWICK & FOTI , LLC (“KSF”) AND KSF PARTNER, FORMER ATTORNEY GENERAL OF LOUISIANA, CHARLES C. FOTI, JR., REMIND INVESTORS THAT THEY HAVE UNTIL DECEMBER 23, 2025 TO FILE LEAD PLAINTIFF APPLICATIONS IN A SECURITIES CLASS ACTION LAWSUIT AGAINST JAMES HARDIE INDUSTRIES PLC (“JAMES HARDIE” OR THE “COMPANY”) (NYSE: JHX), IF THEY PURCHASED OR OTHERWISE ACQUIRED THE COMPANY'S SHARES BETWEEN MAY 20, 2025, AND AUGUST 18, 2025, INCLUSIVE (THE “CLASS PERIOD”). THIS ACTION IS PENDING IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS.
JHX
• Nov. 4, 2025
NEW YORK AND NEW ORLEANS, NOV. 04, 2025 (GLOBE NEWSWIRE) -- KAHN SWICK & FOTI, LLC (“KSF”) AND KSF PARTNER, FORMER ATTORNEY GENERAL OF LOUISIANA, CHARLES C. FOTI, JR., REMIND INVESTORS THAT THEY HAVE UNTIL NOVEMBER 17, 2025 TO FILE LEAD PLAINTIFF APPLICATIONS IN A SECURITIES CLASS ACTION LAWSUIT AGAINST CYTOKINETICS, INCORPORATED (NASDAQGS: CYTK), IF THEY PURCHASED OR OTHERWISE ACQUIRED THE COMPANY'S SECURITIES BETWEEN DECEMBER 27, 2023 AND MAY 6, 2025, INCLUSIVE (THE “CLASS PERIOD”). THIS ACTION IS PENDING IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA.
CYTK
• Nov. 4, 2025
NEW YORK AND NEW ORLEANS, NOV. 04, 2025 (GLOBE NEWSWIRE) -- KAHN SWICK & FOTI , LLC (“KSF”) AND KSF PARTNER, FORMER ATTORNEY GENERAL OF LOUISIANA, CHARLES C. FOTI, JR., REMIND INVESTORS THAT THEY HAVE UNTIL DECEMBER 8, 2025 TO FILE LEAD PLAINTIFF APPLICATIONS IN A SECURITIES CLASS ACTION LAWSUIT AGAINST MAREX GROUP PLC (“MAREX” OR THE “COMPANY”) (NASDAQGS: MRX), IF THEY PURCHASED OR OTHERWISE ACQUIRED THE COMPANY'S SECURITIES BETWEEN MAY 16, 2024 AND AUGUST 5, 2025, INCLUSIVE (THE “CLASS PERIOD”). THIS ACTION IS PENDING IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK.
MRX
• Nov. 4, 2025
NEW YORK AND NEW ORLEANS, NOV. 04, 2025 (GLOBE NEWSWIRE) -- KAHN SWICK & FOTI, LLC (“KSF”) AND KSF PARTNER, FORMER ATTORNEY GENERAL OF LOUISIANA, CHARLES C. FOTI, JR., REMIND INVESTORS THAT THEY HAVE UNTIL DECEMBER 2, 2025 TO FILE LEAD PLAINTIFF APPLICATIONS IN A SECURITIES CLASS ACTION LAWSUIT AGAINST MOLINA HEALTHCARE, INC. (“MOLINA” OR THE “COMPANY”) (NYSE: MOH), IF THEY PURCHASED OR OTHERWISE ACQUIRED THE COMPANY'S SECURITIES BETWEEN FEBRUARY 5, 2025 AND JULY 23, 2025, INCLUSIVE (THE “CLASS PERIOD”). THIS ACTION IS PENDING IN THE UNITED STATES DISTRICT COURT FOR THE CENTRAL DISTRICT OF CALIFORNIA.
MOH
• Nov. 4, 2025
NEW YORK CITY AND NEW ORLEANS, NOV. 04, 2025 (GLOBE NEWSWIRE) -- KAHN SWICK & FOTI, LLC (“KSF”) AND KSF PARTNER, FORMER ATTORNEY GENERAL OF LOUISIANA, CHARLES C. FOTI, JR., REMIND INVESTORS WITH SUBSTANTIAL LOSSES THAT THEY HAVE UNTIL DECEMBER 30, 2025 TO FILE LEAD PLAINTIFF APPLICATIONS IN A SECURITIES CLASS ACTION LAWSUIT AGAINST SYNOPSYS, INC. (“SYNOPSYS” OR THE “COMPANY”) (NASDAQGS: SNPS), IF THEY PURCHASED OR OTHERWISE ACQUIRED THE COMPANY'S SECURITIES BETWEEN DECEMBER 4, 2024 AND SEPTEMBER 9, 2025, INCLUSIVE (THE “CLASS PERIOD”). THIS ACTION IS PENDING IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA.
SNPS
• Nov. 4, 2025
NEW YORK AND NEW ORLEANS, NOV. 04, 2025 (GLOBE NEWSWIRE) -- KAHN SWICK & FOTI, LLC (“KSF”) AND KSF PARTNER, FORMER ATTORNEY GENERAL OF LOUISIANA, CHARLES C. FOTI, JR., REMIND INVESTORS THAT THEY HAVE UNTIL NOVEMBER 18, 2025 TO FILE LEAD PLAINTIFF APPLICATIONS IN A SECURITIES CLASS ACTION LAWSUIT AGAINST KBR, INC. (NYSE: KBR), IF THEY PURCHASED OR OTHERWISE ACQUIRED THE COMPANY'S SECURITIES BETWEEN MAY 6, 2025 AND JUNE 19, 2025, INCLUSIVE (THE “CLASS PERIOD”). THIS ACTION IS PENDING IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF TEXAS.
KBR
• Nov. 4, 2025
NEW YORK AND NEW ORLEANS, NOV. 04, 2025 (GLOBE NEWSWIRE) -- KAHN SWICK & FOTI, LLC (“KSF”) AND KSF PARTNER, FORMER ATTORNEY GENERAL OF LOUISIANA, CHARLES C. FOTI, JR., REMIND INVESTORS THAT THEY HAVE UNTIL NOVEMBER 14, 2025 TO FILE LEAD PLAINTIFF APPLICATIONS IN A SECURITIES CLASS ACTION LAWSUIT AGAINST FLUOR CORPORATION (NYSE: FLR), IF THEY PURCHASED OR OTHERWISE ACQUIRED THE COMPANY'S SECURITIES BETWEEN FEBRUARY 18, 2025 AND JULY 31, 2025, INCLUSIVE (THE “CLASS PERIOD”). THIS ACTION IS PENDING IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF TEXAS.
FLR
• Nov. 4, 2025
NEW YORK AND NEW ORLEANS, NOV. 04, 2025 (GLOBE NEWSWIRE) -- KAHN SWICK & FOTI, LLC (“KSF”) AND KSF PARTNER, FORMER ATTORNEY GENERAL OF LOUISIANA, CHARLES C. FOTI, JR., REMIND INVESTORS THAT THEY HAVE UNTIL NOVEMBER 12, 2025 TO FILE LEAD PLAINTIFF APPLICATIONS IN A SECURITIES CLASS ACTION LAWSUIT AGAINST V.F.
VFC
• Nov. 4, 2025
CULVER CITY, CALIF.--(BUSINESS WIRE)--IMMUNITYBIO, INC. (NASDAQ: IBRX), A LEADING IMMUNOTHERAPY COMPANY, TODAY ANNOUNCED ITS FINANCIAL RESULTS FOR THE FISCAL QUARTER AND NINE MONTHS ENDED SEPTEMBER 30, 2025. IN THE THIRD QUARTER OF 2025, IMMUNITYBIO REPORTED $31.8 MILLION OF PRODUCT REVENUE, REPRESENTING A 434% INCREASE FROM $6.0 MILLION IN THE THIRD QUARTER OF 2024. THIS GROWTH REFLECTS CONTINUED COMMERCIAL TRACTION OF ANKTIVA IN COMBINATION WITH BCG IN BCG-UNRESPONSIVE NMIBC WITH CIS WITH OR.
IBRX
• Nov. 4, 2025
XIAMEN, CHINA , NOV. 4, 2025 /PRNEWSWIRE/ -- EPWK HOLDINGS LTD. (NASDAQ: EPWK) (THE "COMPANY"), A COMPANY THAT CONNECTS BUSINESSES WITH GREAT TALENTS THROUGH INNOVATIVE AND EFFICIENT CLOUD-SOURCING PLATFORMS, TODAY ANNOUNCED THAT THE COMPANY RECEIVED A LETTER (THE "NOTIFICATION LETTER") FROM THE LISTING QUALIFICATIONS STAFF (THE "STAFF") OF THE NASDAQ STOCK MARKET, LLC ("NASDAQ"), NOTIFYING THE COMPANY THAT, AS OF OCTOBER 23, 2025, THE COMPANY'S CLASS A ORDINARY SHARES HAD A CLOSING BID PRICE OF $0.10 OR LESS FOR TEN CONSECUTIVE TRADING DAYS, AND ACCORDINGLY, THE COMPANY IS SUBJECT TO THE PROVISIONS CONTEMPLATED UNDER LISTING RULE 5810(C)(3)(A)(III).
EPWK
• Nov. 4, 2025
PRESS RELEASENOKIA EXTENDS SOFTBANK CORP. PARTNERSHIP WITH NETWORK MODERNIZATION DEAL IN JAPAN NOKIA SELECTED TO MODERNIZE AND EXPAND SOFTBANK'S 4G AND 5G NETWORKS IN JAPAN DEAL INCLUDES NOKIA'S LATEST AIRSCALE PORTFOLIO AND AI-POWERED MANTARAY SOLUTION 5 NOVEMBER 2025 ESPOO, FINLAND – NOKIA TODAY ANNOUNCED AN EXPANSION OF ITS PARTNERSHIP WITH SOFTBANK CORP. (SOFTBANK) THROUGH A NEW DEAL TO SUPPLY ADVANCED 4G AND 5G RADIO ACCESS EQUIPMENT IN JAPAN. THE AGREEMENT ENCOMPASSES THE MODERNIZATION OF EXISTING NETWORK INFRASTRUCTURE AND THE EXPANSION OF 5G STANDALONE COVERAGE USING NOKIA'S CUTTING-EDGE AIRSCALE PORTFOLIO.
SOBKY
• Nov. 4, 2025
NEW YORK , NOV. 4, 2025 /PRNEWSWIRE/ -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF COMMON STOCK OF ATYR PHARMA, INC. (NASDAQ: ATYR) BETWEEN JANUARY 16, 2025 AND SEPTEMBER 12, 2025, BOTH DATES INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT DECEMBER 8, 2025 LEAD PLAINTIFF DEADLINE. SO WHAT: IF YOU PURCHASED ATYR PHARMA COMMON STOCK DURING THE CLASS PERIOD YOU MAY BE ENTITLED TO COMPENSATION WITHOUT PAYMENT OF ANY OUT OF POCKET FEES OR COSTS THROUGH A CONTINGENCY FEE ARRANGEMENT.
ATYR
• Nov. 4, 2025
NEW YORK , NOV. 4, 2025 /PRNEWSWIRE/ -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF COMMON STOCK OF BAXTER INTERNATIONAL INC. (NYSE: BAX) BETWEEN FEBRUARY 23, 2022 AND JULY 30, 2025, BOTH DATES INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT DECEMBER 15, 2025 LEAD PLAINTIFF DEADLINE. SO WHAT: IF YOU PURCHASED BAXTER COMMON STOCK DURING THE CLASS PERIOD YOU MAY BE ENTITLED TO COMPENSATION WITHOUT PAYMENT OF ANY OUT OF POCKET FEES OR COSTS THROUGH A CONTINGENCY FEE ARRANGEMENT.
BAX
• Nov. 4, 2025
NEW YORK , NOV. 4, 2025 /PRNEWSWIRE/ -- WHY: ROSEN LAW FIRM, A GLOBAL INVESTOR RIGHTS LAW FIRM, REMINDS PURCHASERS OF COMMON STOCK OF CYTOKINETICS, INC. (NASDAQ: CYTK) BETWEEN DECEMBER 27, 2023 AND MAY 6, 2025, BOTH DATES INCLUSIVE (THE "CLASS PERIOD"), OF THE IMPORTANT NOVEMBER 17, 2025 LEAD PLAINTIFF DEADLINE. SO WHAT: IF YOU PURCHASED CYTOKINETICS COMMON STOCK DURING THE CLASS PERIOD YOU MAY BE ENTITLED TO COMPENSATION WITHOUT PAYMENT OF ANY OUT OF POCKET FEES OR COSTS THROUGH A CONTINGENCY FEE ARRANGEMENT.
CYTK
• Nov. 4, 2025
LONDON, UK, NOV. 04, 2025 (GLOBE NEWSWIRE) -- ALPHATON CAPITAL CORP ("ALPHATON CAPITAL" OR THE "COMPANY") ( NASDAQ: ATON) - ALPHATON CAPITAL, A LEADING INVESTMENT FIRM FOCUSED ON DISRUPTIVE TECHNOLOGIES, TODAY ANNOUNCED IT HAS ACQUIRED AN ADDITIONAL 300,000 TON COIN TO ADD TO ITS TON DIGITAL ASSET TREASURY.
ATON
• Nov. 4, 2025
PRESENTATION WILL HIGHLIGHT PRECLINICAL DATA SUPPORTING THE POTENTIAL OF WVE-007 (INHBE GALNAC-SIRNA) AS A UNIQUE APPROACH FOR THE TREATMENT OF OBESITY DESIGNED TO DRIVE FAT LOSS WHILE PRESERVING MUSCLE MASS WITH ONCE OR TWICE ANNUAL DOSING
WVE
• Nov. 4, 2025
MILPITAS, CALIF. , NOV. 4, 2025 /PRNEWSWIRE/ -- ZEPP HEALTH CORPORATION ("ZEPP" OR THE "COMPANY") (NYSE: ZEPP) TODAY ANNOUNCED ITS UNAUDITED FINANCIAL RESULTS FOR THE THIRD QUARTER OF 2025.
ZEPP
• Nov. 4, 2025
HOUSTON--(BUSINESS WIRE)--COREBRIDGE FINANCIAL, INC. (NYSE: CRBG) TODAY ANNOUNCED THAT THE PREVIOUSLY ANNOUNCED SECONDARY OFFERING BY AMERICAN INTERNATIONAL GROUP, INC. (NYSE: AIG) OF COMMON STOCK OF COREBRIDGE FINANCIAL HAS PRICED AT $31.10 PER SHARE. THE OFFERING IS EXPECTED TO CLOSE ON NOVEMBER 6, 2025, SUBJECT TO CUSTOMARY CLOSING CONDITIONS. AIG, AS THE SELLING STOCKHOLDER, HAS OFFERED 32.6 MILLION EXISTING SHARES OF COMMON STOCK (OUT OF APPROXIMATELY 520 MILLION TOTAL SHARES OF COMMON STO.
CRBG
• Nov. 4, 2025
NEW YORK--(BUSINESS WIRE)--THE ESTÉE LAUDER COMPANIES INC. (NYSE: EL) TODAY ANNOUNCES THE PRICING OF THE PREVIOUSLY ANNOUNCED REGISTERED PUBLIC OFFERING (THE “OFFERING”) OF THE COMPANY'S CLASS A COMMON STOCK, PAR VALUE $.01 PER SHARE, BY TRUSTS AFFILIATED WITH DESCENDANTS OF LEONARD A. LAUDER (THE “SELLING STOCKHOLDERS”) AT A PRICE TO THE PUBLIC OF $90 PER SHARE. THE SELLING STOCKHOLDERS WILL RECEIVE ALL OF THE PROCEEDS FROM THE OFFERING. THE COMPANY IS NOT SELLING ANY SHARES OF CLASS A COMMON.
EL
• Nov. 4, 2025
THE TRORILUZOLE CLINICAL DEVELOPMENT PROGRAM ENCOMPASSED THE FIRST INDUSTRY CLINICAL TRIALS TO GENERATE DATA SHOWING THERAPEUTIC POTENTIAL IN PATIENTS WITH SPINOCEREBELLAR ATAXIA (SCA), A RARE GENETIC, INHERITED, LIFE-THREATENING NEURODEGENERATIVE DISEASE WITH NO TREATMENT OPTIONS. COMPELLING DATA FROM TRORILUZOLE'S NEW DRUG APPLICATION (NDA) INCLUDED: A 3-YEAR REAL-WORLD EVIDENCE STUDY (STUDY 206-RWE) SHOWING SLOWING OF SCA DISEASE PROGRESSION BY 50-70% IN TRORILUZOLE-TREATED PATIENTS COMPARED TO MATCHED UNTREATED EXTERNAL CONTROLS; > 50% RISK REDUCTION IN AES OF FALLS IN TRORILUZOLE-TREATED SUBJECTS COMPARED TO PLACEBO FROM THE SAFETY ANALYSIS OF THE 1-YEAR, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY -206; AND MULTIPLE SUPPORTIVE ANALYSES SHOWING A DELAY IN BECOMING WHEELCHAIR BOUND OR LOSING THE ABILITY TO WALK, DECREASED GAIT IMPAIRMENT AS MEASURED BY F-SARA AND OBJECTIVE VIDEO-BASED KINEMATIC ANALYSIS, AND IMPROVEMENT IN OVERALL FUNCTIONING AS ASSESSED BY THE CLINICIAN GLOBAL IMPRESSION (CGI) SCALE.
BHVN
• Nov. 4, 2025
